Last reviewed · How we verify

NCT04261868

Virtual Reality Game Playing in Amblyopia Therapy

Status unknown NA Last updated 10 February 2020
What this trial tests

NA trial testing Virtual Reality in Amblyopia in 50 participants. Status unknown.

Timeline
11 March 2020
Primary endpoint
11 May 2021
11 June 2021

Quick facts

Lead sponsorHamideh Sabbaghi
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment50
Start date11 March 2020
Primary completion11 May 2021
Estimated completion11 June 2021

Drugs / interventions tested

Conditions studied

Sponsor

Hamideh Sabbaghi

Who can join

Adults 4 to 10, any sex, with Amblyopia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background: "Amblyopia is a neurodevelopmental disorder in both monocular and binocular functions and it extends even beyond the primary visual integration centers", therefore, amblyopia is not a "lazy eye" but it is a "lazy brain". Purpose: The investigators aimed to compare the visual outcome of occlusion therapy with virtual reality game playing as a new therapy on amblyopic children. Methods: This RCT was performed on 50 children with unilateral amblyopia ,4 to 10 years old. They were randomly divided to case and control (each= 25) groups. case group were trained binocularly using the virtual reality games through head set for one hour a day, 5 days in a week for 4 to 6 weeks. Controls occluded their non- amblyopic eyes, 2, 4 and 6 hours for mild (0.2 to 0.3 LogMAR), moderate (0.3 to 0.6 LogMAR) and severe (BCVA \< 0.6 LogMAR) amblyopia, respectively.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Virtual Reality

Trials testing the same drug.

Other recruiting trials for Amblyopia

Currently open trials in the same condition.

Other Hamideh Sabbaghi trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04261868.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing